Objective. We investigated the effect of oropharyngeal candidiasis (OC) and body mass index (BMI) before antiretroviral therapy (ART) initiation on treatment outcomes of human immunodeficiency virus (HIV)-positive patients. Study Design. Treatment outcomes included failure to increase CD4 count by Ն50 or Ն100 cells/L or failure to suppress viral load (Ͻ400 copies/mL) at 6 or 12 months in addition to loss to follow-up (LTFU) and mortality by 12 months. Risk and hazard ratios (HRs) were estimated with the use of log-binomial regression and Cox proportional hazards models, respectively. Results. Baseline CD4 Ͻ100 cells/L, low BMI (Ͻ18.5 kg/m 2 ), low hemoglobin, and elevated aspartate transaminase were associated with OC at ART initiation. Patients with low BMI with and without, respectively, OC were at risk of mortality (HR 2.42, 95% CI 1.88-3.12; HR 1.87, 95% CI 1.54-2.28) and LTFU (HR 1.36, 95% CI 1.02-1.82; HR 1.55, 95% CI 1.30-1.85). Conclusions. Low BMI (with/without OC) at ART initiation was associated with poor treatment outcomes. Conversely, normal BMI with OC was associated with adequate CD4 response and reduced LTFU compared with without
Oropharyngeal candidiasis (OC), a fungal infection of the mouth and/or throat which presents with increasing pain and difficulty in swallowing (dysphagia), has been associated with human immunodeficiency virus (HIV) infection since the advent of the acquired immunodeficiency syndrome (AIDS) pandemic. 1 Oral manifestations of HIV/AIDS occur in Ͼ60% of HIV-positive patients and are often the first sign of underlying immune suppression. [1] [2] [3] [4] [5] [6] [7] OC is strongly associated with a low CD4 lymphocyte count and a rising HIV viral load. 5, 6, 8 It is one of the earliest manifestations of HIV disease in high-risk individuals not undergoing chemotherapy and is also a strong predictor of the subsequent risk of AIDS-related illness or death. 9, 10 OC has been used in resource-limited settings (RLS) as a guide for when to initiate antiretroviral therapy (ART) and is a clinical pointer to HIV infection in individuals who do not know their HIV status. 2 The prevalence of OC varies widely among different geographic regions and population groups and in Africa ranges from 34.9% in Cameroon to 80% in Kenya. 1 Malnutrition refers to a range of conditions that develop when the body does not receive optimal amounts of the vitamins, minerals, and other nutrients needed to maintain healthy tissues and organ function. It may be caused by inadequate diet and undernutrition. [11] [12] [13] Numerous nutrition risk screening or assessment tools have been developed to identify patients at risk of malnutrition. 14, 15 These tools offer a simple technique to rapidly identify patients and provide a basis for prompt dietetic referrals, but they are underutilized or not readily available in the HIV RLS. However, the measurement of selected anthropometric indexes (weight, height, waist-hip ratio, middle upper arm circumference, and body mass index [BMI] ), 16 biochemical variables (serum albumin concentration, transferrin, prealbumin, retinol binding protein, ceruloplasmin, plasma fibronectin, and C-reactive protein), immunologic variables (absolute lymphocyte count, lowered CD4 counts, and delayed hypersensitivity skin testing), and clinical judgment can be used to assess nutritional status. 17 Unplanned weight loss, lipodystrophy, reduced dietary intake, or limited access to food together with symptoms (nausea, diarrhea, vomiting, loss of appetite, fatigue, heartburn, bloating), concomitant drug use (ART or tuberculosis [TB] drugs), and the presence/ absence/severity of disease (diabetes, cancer, hypertension) are used to identify risk of, and to diagnose, malnutrition. 14, 16 Both BMI and weight loss have been used as independent predictors of disease progression and are useful markers to indicate malnutrition. 13 The World Health Organization (WHO) uses BMI to grade nutritional status in the following manner: mild malnutrition (BMI 17.00-18.49), moderate malnutrition (BMI 16.00-16.99), and severe malnutrition (BMI Ͻ16.00).
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HIV-positive patients are more vulnerable to malnutrition because they may have impaired nutrient absorption (due to diarrhea/intestinal tract damage), reduced food intake (due to symptoms such as vomiting or pain on swallowing), food insecurity, or poverty, as well as functional changes and medication side effects, such as loss of appetite, depression, or abdominal pain. 12, 16, 19 Opportunistic infections can affect food intake, absorption, and metabolism and thereby cause weight loss. According to Rollins et al., 20 the populations at greatest risk of HIV infection are also at risk of food insecurity and therefore might already be malnourished before the onset of HIV. Malnutrition in HIV-positive patients causes severe immunodeficiency with depletion of CD4 cells and increase in HIV viral replication, ultimately increasing susceptibility to opportunistic infections and infectious diseases. [21] [22] [23] Thus, a cycle of infection, malnutrition, and immunodeficiency has been described ( Figure 1) . 12, 13, 19 Although the statistics in South Africa on the prevalence of OC in the pediatric population ranges from 13.8% to 63%, there are limited data on the prevalence of the condition in HIV-positive adults at ART initiation. 24, 25 Additionally, few studies have explored OC in relation to malnutrition among HIVinfected persons, and little evidence exists on either topic in RLS. 6 The factors contributing to the development and progression of OC are poorly understood but may include an interrelationship between HIV and Candida and/or dysfunction in local immunity, superimposed on weakened cell-mediated immunity and depletion of CD4 T cells. 1 OC and malnutrition have each been identified as independent predictors of disease progression 9, 10, 13, 26 ; however, the combined effect of OC and malnutrition before ART initiation on treatment outcomes has not been described in RLS. This combined effect may lead to poorer treatment outcomes compared with HIVpositive patients with OC or malnutrition alone at ART initiation. Furthermore, because OC has been associated with HIV infection and underlying immune suppression, we anticipate poorer treatment outcomes in patients that present with OC.
We analyzed data from a large urban cohort of ARTnaive individuals eligible for initiation of ART to determine the proportion and characteristics of patients who present with OC and/or low BMI. We tested the association between OC and features of malnutrition in HIV-positive patients and investigated the effectiveness of OC and/or low BMI as clinical markers of disease progression. We also estimated the effect of OC and/or low BMI on treatment outcomes, including failure to achieve an adequate viral load or CD4 count response at 6 or 12 months after ART initiation, as well as on mortality and loss to follow-up (LTFU) by 12 months after ART initiation.
MATERIALS AND METHODS

Study site and subjects
The study was a retrospective analysis of existing data collected from a cohort of HIV-infected adults initiated on ART at the Themba Lethu Clinic (TLC), Johannesburg. The TLC is an urban public-sector HIV Comprehensive Care Management and Treatment (CCMT) site. Since the start of the national CCMT program in April 2004, more than 26,000 adults been recruited to the Themba Lethu clinical cohort, of whom more than 16,000 started ART. According to South African National Department of Health guidelines, patients at TLC are initiated onto a standard public-sector first-line regimen of stavudine (d4T) or zidovudine (AZT) with lamivudine (3TC) and either efavirenz (EFV) or nevirapine (NVP). 27 Patients are eligible for ART initiation if their CD4 cell count is Ͻ200 cells/L regardless of WHO stage or they have a WHO stage IV AIDSdefining illness regardless of CD4 count. 27 Longitudinal clinical and demographic data are collected and stored on the electronic patient management system, TherapyEdge-HIV. Use of TLC data were approved by the Human Research Ethics Committee of the University of the Witwatersrand (HREC-Medical M060626/ M110140).
Eligibility criteria
Out of a total of 16,496 HIV-positive individuals initiated on ART, we excluded patients who had a previ-ous ART-drug history (i.e., patients transferred to TLC from another facility or earlier clinical trial patients) at presentation to the clinic (n ϭ 4,146), patients Ͻ18 years of age (n ϭ 45), pregnant women (because BMI and nutrient metabolism vary during pregnancy; n ϭ 125), 28 or patients who were initiated on ART outside the study period of April 01, 2004 -April 01, 2009 (n ϭ 2,358). Finally, we excluded patients who did not have a BMI (kg/m
2 ) recorded at initiation of ART (n ϭ 1,413). The remaining 8,409 subjects were included in the analysis.
Study variables
Individuals were classified as having OC at initiation if a clinical diagnosis of OC (WHO stage III or IV) was recorded at baseline (defined as any measurement between 90 days before to 7 days after ART initiation). 29, 30 This was confirmed if the clinical diagnosis corresponded to a prescription of nystatin or fluconazole (both obtained from medical records). Because the standard biochemical variables to assess nutritional status 17 are not routinely collected in this cohort, proxies for poor nutritional status or malnutrition, such as hemoglobin (Hb; Ͻ8 g/dL) 31 and aspartate transaminase (AST; Ͼ45 IU/L), 32 were included in the analysis. Severe anemia, defined as a Hb concentration Ͻ8 g/dL, has been linked to malnutrition and is an independent predictor of HIV disease progression. 15, 31, 33 High values of AST (Ͼ45 IU/L) have been reported in protein-energy malnutrition, and increased liver enzymes have been associated with a high consumption of maize meal and low consumption of meat and vegetables. 34 HIV infection and immune suppression at baseline was determined by an HIV viral load of Ն20,000 copies/mL, 5, 35 and a CD4 cell count of Ͻ50 cells/L or Ͻ100 cells/L, respectively. 36, 37 Fig. 1. Interaction between nutritional status and HIV disease progression: A cycle of infection, malnutrition, and immunodeficiency has been described. Opportunistic infections are responsible for reduced intake and place people living with HIV/AIDS at a high risk of developing malnutrition. Nutritional deficiencies are responsible for HIV disease progression as insufficient antioxidants and increased oxidative stress leads to increased HIV viral replication and depletion of CD4 cells. OI, opportunistic infection; OC, oropharyngeal candidiasis; GIT, gastrointestinal tract; HAART, highly active antiretroviral therapy; BMI, body mass index.
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Patients were categorized as follows: 1) patients without OC before ART initiation and BMI Ն18.5 kg/m 2 (normal); 2) patients with a diagnosis of OC before ART initiation and BMI Ն18.5 kg/m 2 ; 3) patients with BMI Ͻ18.5 kg/m 2 and without OC before ART initiation; and 4) patients with a diagnosis of OC before ART initiation and BMI Ͻ18.5 kg/m 2 .
Outcomes
We assessed failure to achieve an adequate viral load response (defined as a failure to suppress or a detectable HIV viral load Ն400 copies/mL at 6 or 12 months after ART initiation) and failure to achieve an adequate CD4 count response (defined as failure to increase CD4 count to Ն50 cells/L by 6 months or to Ն100 cells/L by 12 months after ART initiation). 36, 37 In addition, we compared ART outcomes (LTFU and mortality) by 12 months of follow-up stratified by OC and/or low BMI at ART initiation. LTFU was defined as having missed a clinic appointment (clinical assessment, antiretroviral drug pickup, counselor visit) by Ն3 months after the scheduled visit date. [38] [39] [40] Mortality was ascertained via South Africa's national vital registration system. [38] [39] [40] For death or LTFU, person-time accrued from ART initiation until the earliest of: death, LTFU, completed 12 months of follow-up, or close of the dataset on April 01, 2010. Patients who transfered to another facility were censored at their last clinic visit.
Statistical analysis
Patient characteristics and outcomes were stratified by OC and/or low BMI at ART initiation and summarized as simple proportions. Groups with OC and/or low BMI were compared with the normal group with the use of Student t test or Kruskal-Wallis test for continuous variables and 2 test for proportions. We estimated the strength of association of an oral lesion before ART initiation with features of malnutrition, HIV infection, and immune suppression. 23 Logbinomial regression analysis was used to estimate the relative risk (RR) and 95% confidence interval (CI) of prevalent OC lesions at ART initiation with the following factors: 1) CD4 cell count Ͻ100 cells/L or Ͻ50 cells/L, 2) HIV viral load Ն20,000 copies/mL, 5, 35 3) BMI Ͻ18.5 kg/m 2 , 11,12,16,18 4) Hb Ͻ8.0 g/dL, 31 and 5) AST Ͼ45 IU/L at ART initiation. 32 We used log-binomial regression models to estimate the RR and 95% confidence interval (CI) of OC and/or low BMI on failure to achieve an adequate viral load or CD4 count response at 6 or 12 months after ART initiation.
We compared ART outcomes (mortality and LTFU) by 12 months' follow-up with the use of Cox proportional hazard models, Kaplan-Meier curves, and logrank tests. Factors such as age, gender, CD4 count, Hb, AST, and TB at initiation of ART were included in models where appropriate. All analyses were performed with SAS version 9.1 (SAS Institute, Cary, North Carolina). 2 ). Patients with normal or low BMI with OC showed elevated AST (Ͼ45 IU/L) levels compared with patients without OC (normal BMI: 31% vs. 24%; low BMI: 41% vs. 35%) but also showed a decline in immune competence, with 44.3% and 59.6%, respectively, having a CD4 cell count Ͻ50 cell/L (Table I) . (Table I) .
RESULTS
Association of OC with features of malnutrition, HIV infection, and immune function
Viral load and CD4 response
Adjusted log-binomial regression models showed that patients with OC at initiation were more likely to achieve an adequate CD4 response (RR 0. (Table II) . Table III) . Additionally, crude Kaplan-Meier survival curves showed that patients with low BMI and no OC were at highest risk for LTFU (log-rank test: P Ͻ .001; Figure  2 , A), whereas those with low BMI and OC at initiation were at highest risk for mortality by 12 months of follow-up (log-rank test: P Ͻ .001; Figure 2 , B).
Mortality and loss to follow-up
DISCUSSION
Malnutrition is associated with many adverse outcomes, including depression of the immune system, impaired wound healing, muscle wasting, longer lengths of hospital stay, higher treatment costs, and increased mortality, in elderly, hospitalized, and diabetic patients, not just HIV-positive patients. 14 We demonstrate that patients with low BMI (with or without OC) at initiation of ART have poorer treatment outcomes in terms of LTFU and mortality compared with patients with no OC and normal BMI. Patients with BMI Ͻ18.5 kg/m 2 at ART initiation were more likely to have a detectable viral load (Ն400 copies/mL) and were at increased risk of mortality and LTFU by 12 months after ART initiation compared with normal patients. Because a cycle of infection, malnutrition, and immunodeficiency has been described 12, 13, 19 ( Figure  1) , it is important to identify and treat these patients early to reduce viral replication and disease progression, limit drug resistance due to ongoing viral burden, and improve treatment outcomes. Furthermore, we demonstrate that OC at ART initiation is associated with immune suppression and features of malnutrition, including low BMI, low Hb, and elevated AST levels.
The number of undernourished people of all ages in sub-Saharan Africa increased from about 90 million in 1970 to 225 million in 2008 and is projected to increase by another 100 million by 2015. 41 Both malnutrition and opportunistic infections can worsen HIV disease progression and prognosis and may be a cause as well as a result of immunologic dysfunction. 11, 19, 42 Nutritional deficiencies from HIV-related metabolic changes can contribute to anemia, malnutrition (loss of body a,b,c,d,e,i,I,l,m,n,o,p,t,w,x,y weight, low BMI, and low CD4 cell count), and opportunistic infections. 34 Maize meal or pap (smooth maize meal porridge) is the staple diet of many people, especially black Africans in South Africa. Considering a diet consisting mainly of carbohydrates, 16 with a poor nutritional intake, it is feasible that proxies for nutritional status (high AST, low BMI, and low Hb) indicate malnutrition as a consequence of poor nutrition and altered nutrient absorption or metabolic changes related to HIV-infection. Severe anemia is common among people with low incomes or low socioeconomic backgrounds, probably owing to malnutrition. 31 Increased liver enzymes signify poor nutritional status associated with a high consumption of maize meal and lower consumption of meat and vegetables, which results in an inadequate intake of nutrients and poor nutritional status. 34 High levels of AST have been reported in HIV-positive patients not on ART therapy 43 ; it has also been reported with protein-energy malnutrition, 44 where levels increase according to the severity. The single most important factor that leads to malnourishment is poverty. 45 Employment status, a proxy for social class, indicates that more than 50% of this cohort has a low socioeconomic status.
Other factors may also contribute to malnutrition. Active TB is associated with wasting, low BMI, micronutrient deficiencies, and anemia. Because a higher rate of TB coinfection was reported in patients present- Abbreviations as in Table II . *Adjusted for hemoglobin, CD4 count, aspartate transaminase, tuberculosis, age, and sex at ART initiation. †Loss to follow-up defined as Ն3 months since last visit. ‡Mortality obtained from South African National Vital Registration Infrastructure Initiative.
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368 Evans et al. March 2012 ing with OC, it is feasible that TB may aggravate malnutrition. There are limited data on the relationship between malnutrition and the incidence of TB, but it has been suggested that general malnutrition reduces the expression of mycobactericidal substances, which may compromise cell-mediated immunity and lead to active TB. 46 Despite the high prevalence of TB at ART initiation in this cohort, TB did not contribute to an increased risk of LTFU or mortality.
The prevalence of HIV-related oral lesions and malnutrition in developing countries remains high, because ART use is limited. 47, 48 The prevalence of OC (18%) in this cohort was similar to that reported for pediatric HIV-positive orphans from Gauteng, South Africa, 25 but lower than those reported for other regions in Africa. 1 Multiple studies on the prevalence of HIV-related oral lesions conducted in industrialized countries before and after the availability of ART have shown that OC is the most common and frequent HIV-related oral condition. 7, 49, 50 Results from the present study are consistent with earlier findings that ART can help to dramatically decrease the number of OC lesions by 12 and 24 months after ART initiation. 6, 7, 9, 51, 52 According to the South African ART treatment guidelines, adults and adolescents are initiated on ART if they have a WHO stage IV AIDS-defining illness, regardless of CD4 count. 27 Because patients with OC are initiated regardless of CD4 count, some of these patients may present at the clinic sooner in search of treatment for their symptoms. In a subanalysis of all patients with OC at ART initiation, patients with OC were initiated onto ART quicker than patients that presented without OC (P ϭ .002). This may be responsible for the improved outcomes after initiation and may explain why these patients are more likely to achieve an adequate viral load and CD4 response after ART initiation. Results suggest that ART dramatically decreases OC and promotes immune reconstitution, improving survival and LTFU rates. Additionally, 2 studies have shown that patients with a history of opportunistic infections have increased adherence. 53, 54 The authors of those studies postulate that experience with illness motivates adherence and healthy behavior.
Patients with OC and normal BMI are at the lowest risk for death and LTFU by 12 months of follow-up, whereas patients with low BMI and no OC or those with a combination of OC and low BMI are at a higher risk for LTFU and mortality, compared with normal patients. Patients with low BMI and no OC at initiation were more likely to have a detectable viral load and were at increased risk of mortality and LTFU by 12 months after ART compared with normal patients.
After ART initiation, patients with OC and normal BMI are more likely to achieve an adequate viral and CD4 response (although not all of these estimates are precise) and less likely to be LTFU compared with those that present without OC, possibly as a result of ART and improved adherence to ART. 53, 54 Patients presenting with low BMI (with or without OC) have an Patients with a diagnosis of OC and normal BMI, patients with no OC and BMI Ͻ18.5 kg/m 2 , and patients with a diagnosis of OC and BMI Ͻ18.5 kg/m 2 before ART initiation were compared with normal patients (without OC and BMI Ն18.5 kg/m 2 ). Log-rank test for loss to follow-up and mortality was P Ͻ .001. Patients presenting with low BMI (with or without OC) at ART initiation have poorer treatment outcomes and markedly diminished survival rates by 12 months compared with those with normal BMI (without OC). Conversely, normal BMI with OC was associated with adequate CD4 response and reduced loss to follow-up. The combination of OC and malnutrition at initiation of ART may be a useful clinical marker of HIV disease progression.
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ORIGINAL ARTICLE Volume 113, Number 3 increased risk of mortality and LTFU, confirming that low BMI is a strong predictor of LTFU and mortality.
Our findings should be considered in light of the study limitations. First, we had no micronutrient or macronutrient data to confirm the assumption that there were nutritional deficiencies. Deficiencies in vitamins A, B 12 , E, and C, selenium, zinc, and iron need to be confirmed in this study population. Second, the study represents patients from one large government ART site, so results may not be generalizable to other regions or clinics. However, the demographics of patients in this study are similar to the HIV/AIDS patient profile in South Africa, i.e., black African, female, 15-49 years old, unemployed, low socioeconomic status. 38, 45 Also, malnutrition in a rural setting may be different from that in an urban setting, because additional risk factors, such as socioeconomic status, environmental conditions, hygiene conditions (i.e., inadequate housing, absence of water and sanitation), and food availability may be poorer. Third, 1,413/16,496 (8.6%) of the patients without baseline BMI were excluded from the analysis, which may introduce selection bias. However, the baseline clinical and demographic characteristics of this group, such as age at initiation 36.5 years (IQR 31.5-42.3), female sex 63.6%, CD4 cell count 69 cells/L (IQR 22-142), and Hb 11.3 g/dL (IQR 9.5-12.8), were similar to those included in the analysis (Table I) .
Fourth, OC is a WHO stage III/IV condition, where a presumptive and definitive diagnosis is made on the basis of clinical signs/macroscopic appearance and confirmatory diagnostic testing or laboratory studies are not necessary. A relatively simple way to confirm the suspected diagnosis is to scrape the plaques with a tongue blade to reveal an inflamed and/or bleeding base. In this study, patients were classified as having OC at ART initiation if a clinical diagnosis was recorded in our patient database (TherapyEdge-HIV), so the prevalence of OC (18%) may be under-or overestimated in this population. According to guidelines applicable to this setting, OC is diagnosed clinically and lesions are not smeared or cultured routinely, which may be a potential weakness in this study. However, clinicians are intensively trained in the history, clinical appearance, examination, and treatment of infections such as OC, and ultimately each clinician uses his or her discretion in making a clinical diagnosis. The clinical team at this site is supported and assisted by highly experienced specialist HIV and infectious diseases consultants. Because nystatin and fluconazole are also commonly used to treat OC, 55 this was included to support a diagnosis of OC at ART initiation. Five hundred nineteen patients were prescribed nystatin or fluconazole at ART initiation but a clinical diagnosis of OC could not be confirmed. These antifungal drugs can be prescribed for cutaneous, vaginal, mucosal, and esophageal Candida infections. If these individuals are included in the analysis as having OC at ART initiation, the prevalence increases to 24.8%. The estimates (compared with normal) for LTFU for those with OC and normal BMI, low BMI and no OC, and OC with low BMI at initiation are then HR 0.73 (IQR 0.63-0.86), HR 1.30 (1.08 to 1.57), and HR 2.01 (IQR 1.63-2.48), respectively, and the estimates for mortality are then HR 1.47 (IQR 1.29-1.68), HR 1.22 (IQR 0.97-1.53), and HR 2.37 (1.87 to 3.01), respectively. Fifth, the Candida isolates or the resistance profile to antifungal drugs in these HIV-infected patients is not known, and this may contribute to morbidity and mortality. 49 Finally, although opportunistic infections affect food intake which places people living with HIV/AIDS at a high risk of developing malnutrition, the authors are not suggesting a causal link but rather report an association between OC and malnutrition.
CONCLUSION
Malnutrition is considered to be a major underlying factor in the full clinical expression of AIDS in HIVinfected individuals. 56, 57 We demonstrate that patients with OC and normal BMI at ART initiation are more likely to achieve an adequate CD4 response and less likely to be LTFU, whereas patients with a combination of OC and low BMI have the highest risk of mortality and are at increased risk of LTFU compared with normal patients. Patients presenting with low BMI (with or without OC) have poorer treatment outcomes and markedly diminished survival rates, highlighting the need for early recognition with subsequent ART and micronutrient supplementation to help reduce mortality. Studies validating these data are important for demonstrating that the combination of OC and malnutrition at initiation of ART could be used as a clinical marker of HIV disease progression.
